Work

Sequential administration of dose-dense epirubicin/cyclophosphamide followed by docetaxel/capecitabine for patients with HER2-negative and locally advanced or node-positive breast cancer

Year: 2009

Type: article

Study design: Clinical Trial

Source: Cancer Chemotherapy and Pharmacology

DOI: 10.1007/s00280-009-1049-y

Authors: Yago Nieto, José Manuel Aramendía, Jaime Espinós, Susana De la Cruz, Oscar Fernández-Hidalgo, Marta Santisteban, Leyre Arbea, Javier Aristu, Rafael Martínez-Monge, Marta Moreno, Luis Pina, Josu Sola, Gerardo Zornoza, Fernando Martínez Regueira

Institution: Clinica Universidad de Navarra

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Cancer Institute

Award: Cancer Center Support Grant

OpenAlex ID: W2132940515

FWCI: 0.448

Cites: 47

Cited by: 6

Related to: 10